Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...
Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...
Dr. Xiaohu Zhang, co-founder and CEO of Accropeutics said, "Dosing of the first patient in AC-101's Phase 1b study represents a significant step towards advancing this novel oral therapeutic for ...
Severe abdominal pains, unpredictable bowel movements and fatigue are some of the serious symptoms 180,000 Australians live ...
Good Housekeeping UK on MSN14h
Weightloss drugs: five extra benefits for your healthYes, weightloss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
A new study suggests that men with inflammatory bowel disease (IBD) may face a significantly higher risk of developing heart disease over time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback